Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium.
OBJECTIVE
To assess the effectiveness of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium.


METHODS
Thirty-four eyes with recurrent pterygium underwent surgical excision followed by the intraoperative application of low-dose (0.05%) mitomycin C and the use of limbal conjunctival autograft. All patients were observed for at least 18 months for any complications, including recurrences.


RESULTS
Neither recurrences nor serious complications were recorded. Visual acuity improved significantly (P < .05) in eyes with pterygium extending 3 mm or more beyond the limbus.


CONCLUSIONS
Simple excision and low-dose mitomycin C followed by limbal conjunctival autograft is a safe and effective way of treating recurrent pterygium.
Nabawi
Khaled S
KS
Faculty of Medicine, Alexandria University Hospitals, Egypt.
Ghonim
Mahfouz A
MA
Ali
Mohamad H
MH
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D003228:Conjunctiva / Q000637:transplantation*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage*; D011446:Prospective Studies; D011625:Pterygium / Q000188:drug therapy* / Q000601:surgery*; D012008:Recurrence; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D014792:Visual Acuity
D000903:Antibiotics, Antineoplastic; D016685:Mitomycin